FMC (FMC) AGM 2026 summary

Opening remarks and agenda

• Chairman and CEO welcomed shareholders and introduced board members and meeting rules.

• Remembered a recently deceased director and recognized three retiring board members for their service.

• Introduced KPMG representatives and outlined the meeting's order of business.

Financial performance review

• Reported 2025 revenue of $3.47 billion, down 18% from 2024; adjusted EBITDA was $843 million, down 7%.

• Adjusted earnings per share were $2.96, down 15% from 2024; EBITDA margin remained strong at 22%.

• Divested commercial business in India due to market challenges; will maintain supply agreements and R&D presence.

• Launched Project Foundation to optimize manufacturing and reduce costs, including relocating production of two active ingredients.

• Sales of three new active ingredients rose 54% to $200 million; innovation pipeline expected to exceed $2 billion in sales at maturity.

Board and executive committee updates

• Three board members retired after long tenures, recognized for contributions to governance and sustainability.

• Nine directors nominated for election for a one-year term; one nominee removed due to passing.